Macao vs Peru: Previously treated cases tested for RR-/MDR-TB
Macao
96.0%
in 2024
Peru
95.0%
in 2024
Macao rank
65th
Peru rank
66th
Previously treated cases tested for RR-/MDR-TB over time
- Macao
- Peru
How they compare
Macao currently reports 96.0% against 95.0% in Peru, a difference of 1.0%.
The two have swapped places 2 times across 19 shared years of data; in 2005 it was Macao ahead.
Macao ranks 65th and Peru ranks 66th of 180 countries.
Macao has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Macao | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.8% | 27.2% | 39.6% | Macao |
| 2010s | 86.1% | 71.2% | 14.9% | Macao |
| 2020s | 95.4% | 82.4% | 13.0% | Macao |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Macao or Peru?
- Macao, at 96.0% against 95.0% in Peru as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Macao and Peru?
- 1.0%, with Macao ahead.
- How many years of comparable data are there for Macao and Peru?
- 19 years are reported by both, from 2005 to 2024.
- How do Macao and Peru rank globally for previously treated cases tested for rr-/mdr-tb?
- Macao ranks 65th and Peru ranks 66th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.